{
  "DOI": "10.1038/s41431-020-00751-3",
  "ISSN": [
    "1018-4813",
    "1476-5438"
  ],
  "URL": "http://dx.doi.org/10.1038/s41431-020-00751-3",
  "abstract": "\u003cjats:title\u003eAbstract\u003c/jats:title\u003e\u003cjats:p\u003eDNA variants affecting mRNA expression and processing in genetic diseases are often missed or poorly characterized. We previously reported a generic assay to identify variants that affect mRNA expression and splicing in Pompe disease, a monogenic disorder caused by deficiency of acid α-glucosidase (\u003cjats:italic\u003eGAA\u003c/jats:italic\u003e). However, this assay could miss mRNA that is subjected to degradation. Here, we inhibited mRNA degradation using cycloheximide and performed unbiased splicing analysis of all \u003cjats:italic\u003eGAA\u003c/jats:italic\u003e exons using exon flanking RT-PCR and exon internal RT-qPCR. In four patients that were suspected of harboring splicing variants but for which aberrant splicing could not be detected in normally growing cells, we detected a total of 10 novel splicing events in cells treated with cycloheximide. In addition, we found that sequences of \u003cjats:italic\u003eGAA\u003c/jats:italic\u003e introns 6 and 12 were naturally included in a subset of transcripts from patients and healthy controls, indicating inefficient canonical splicing. Identification of aberrant splicing caused by the common Asian variant c.546G\u0026gt;T allowed the development of an antisense oligonucleotide that promoted canonical \u003cjats:italic\u003eGAA\u003c/jats:italic\u003e pre-mRNA splicing and elevated GAA enzymatic activity. Our results indicate that this extended generic splicing assay allows the detection of aberrant splicing in cases of mRNA degradation to enable functional analysis of unknown splicing variants and the development of targeted treatment options.\u003c/jats:p\u003e",
  "alternative-id": [
    "751"
  ],
  "assertion": [
    {
      "group": {
        "label": "Article History",
        "name": "ArticleHistory"
      },
      "label": "Received",
      "name": "received",
      "order": 1,
      "value": "25 February 2020"
    },
    {
      "group": {
        "label": "Article History",
        "name": "ArticleHistory"
      },
      "label": "Revised",
      "name": "revised",
      "order": 2,
      "value": "10 September 2020"
    },
    {
      "group": {
        "label": "Article History",
        "name": "ArticleHistory"
      },
      "label": "Accepted",
      "name": "accepted",
      "order": 3,
      "value": "20 October 2020"
    },
    {
      "group": {
        "label": "Article History",
        "name": "ArticleHistory"
      },
      "label": "First Online",
      "name": "first_online",
      "order": 4,
      "value": "9 November 2020"
    },
    {
      "group": {
        "label": "Compliance with ethical standards",
        "name": "EthicsHeading"
      },
      "name": "Ethics",
      "order": 1
    },
    {
      "group": {
        "label": "Conflict of interest",
        "name": "EthicsHeading"
      },
      "name": "Ethics",
      "order": 2,
      "value": "ATvdP provided consultancy services for various industries. All other authors declare that they have no conflict of interest."
    }
  ],
  "author": [
    {
      "affiliation": [],
      "family": "Bergsma",
      "given": "Atze J.",
      "sequence": "first"
    },
    {
      "affiliation": [],
      "family": "in ’t Groen",
      "given": "Stijn L. M.",
      "sequence": "additional"
    },
    {
      "affiliation": [],
      "family": "Catalano",
      "given": "Fabio",
      "sequence": "additional"
    },
    {
      "affiliation": [],
      "family": "Yamanaka",
      "given": "Manjiro",
      "sequence": "additional"
    },
    {
      "affiliation": [],
      "family": "Takahashi",
      "given": "Satoru",
      "sequence": "additional"
    },
    {
      "affiliation": [],
      "family": "Okumiya",
      "given": "Toshika",
      "sequence": "additional"
    },
    {
      "affiliation": [],
      "family": "van der Ploeg",
      "given": "Ans T.",
      "sequence": "additional"
    },
    {
      "ORCID": "http://orcid.org/0000-0002-7042-2482",
      "affiliation": [],
      "authenticated-orcid": false,
      "family": "Pijnappel",
      "given": "W. W. M. Pim",
      "sequence": "additional"
    }
  ],
  "container-title": [
    "European Journal of Human Genetics"
  ],
  "content-domain": {
    "crossmark-restriction": false,
    "domain": [
      "link.springer.com"
    ]
  },
  "created": {
    "date-parts": [
      [
        2020,
        11,
        9
      ]
    ],
    "date-time": "2020-11-09T09:09:41Z",
    "timestamp": 1604912981000
  },
  "deposited": {
    "date-parts": [
      [
        2023,
        5,
        20
      ]
    ],
    "date-time": "2023-05-20T21:01:02Z",
    "timestamp": 1684616462000
  },
  "indexed": {
    "date-parts": [
      [
        2024,
        4,
        16
      ]
    ],
    "date-time": "2024-04-16T20:13:35Z",
    "timestamp": 1713298415129
  },
  "is-referenced-by-count": 6,
  "issn-type": [
    {
      "type": "print",
      "value": "1018-4813"
    },
    {
      "type": "electronic",
      "value": "1476-5438"
    }
  ],
  "issue": "3",
  "issued": {
    "date-parts": [
      [
        2020,
        11,
        9
      ]
    ]
  },
  "journal-issue": {
    "issue": "3",
    "published-print": {
      "date-parts": [
        [
          2021,
          3
        ]
      ]
    }
  },
  "language": "en",
  "license": [
    {
      "URL": "https://creativecommons.org/licenses/by/4.0",
      "content-version": "tdm",
      "delay-in-days": 0,
      "start": {
        "date-parts": [
          [
            2020,
            11,
            9
          ]
        ],
        "date-time": "2020-11-09T00:00:00Z",
        "timestamp": 1604880000000
      }
    },
    {
      "URL": "https://creativecommons.org/licenses/by/4.0",
      "content-version": "vor",
      "delay-in-days": 0,
      "start": {
        "date-parts": [
          [
            2020,
            11,
            9
          ]
        ],
        "date-time": "2020-11-09T00:00:00Z",
        "timestamp": 1604880000000
      }
    }
  ],
  "link": [
    {
      "URL": "http://www.nature.com/articles/s41431-020-00751-3.pdf",
      "content-type": "application/pdf",
      "content-version": "vor",
      "intended-application": "text-mining"
    },
    {
      "URL": "http://www.nature.com/articles/s41431-020-00751-3",
      "content-type": "text/html",
      "content-version": "vor",
      "intended-application": "text-mining"
    },
    {
      "URL": "http://www.nature.com/articles/s41431-020-00751-3.pdf",
      "content-type": "application/pdf",
      "content-version": "vor",
      "intended-application": "similarity-checking"
    }
  ],
  "member": "297",
  "page": "422-433",
  "prefix": "10.1038",
  "published": {
    "date-parts": [
      [
        2020,
        11,
        9
      ]
    ]
  },
  "published-online": {
    "date-parts": [
      [
        2020,
        11,
        9
      ]
    ]
  },
  "published-print": {
    "date-parts": [
      [
        2021,
        3
      ]
    ]
  },
  "publisher": "Springer Science and Business Media LLC",
  "reference": [
    {
      "DOI": "10.1016/S0140-6736(08)61555-X",
      "author": "AT van der Ploeg",
      "doi-asserted-by": "publisher",
      "first-page": "1342",
      "journal-title": "Lancet",
      "key": "751_CR1",
      "unstructured": "van der Ploeg AT, Reuser AJ. Pompe’s disease. Lancet. 2008;372:1342–53.",
      "volume": "372",
      "year": "2008"
    },
    {
      "DOI": "10.1002/humu.23854",
      "doi-asserted-by": "crossref",
      "key": "751_CR2",
      "unstructured": "Nino MY, In ‘t Groen SLM, Bergsma AJ, van der Beek N, Kroos M, Hoogeveen-Westerveld M, et al. Extension of the Pompe mutation database by linking disease-associated variants to clinical severity. Hum Mutat. 2019;40:1954–67."
    },
    {
      "DOI": "10.1002/ajmg.c.31318",
      "author": "M Kroos",
      "doi-asserted-by": "publisher",
      "first-page": "59",
      "journal-title": "Am J Med Genet C Semin Med Genet",
      "key": "751_CR3",
      "unstructured": "Kroos M, Hoogeveen-Westerveld M, van der Ploeg A, Reuser AJ. The genotype-phenotype correlation in Pompe disease. Am J Med Genet C Semin Med Genet. 2012;160C:59–68.",
      "volume": "160C",
      "year": "2012"
    },
    {
      "DOI": "10.1002/humu.22705",
      "author": "AJ Bergsma",
      "doi-asserted-by": "publisher",
      "first-page": "57",
      "journal-title": "Hum Mutat",
      "key": "751_CR4",
      "unstructured": "Bergsma AJ, Kroos M, Hoogeveen-Westerveld M, Halley D, van der Ploeg AT, Pijnappel WW. Identification and characterization of aberrant GAA pre-mRNA splicing in pompe disease using a generic approach. Hum Mutat. 2015;36:57–68.",
      "volume": "36",
      "year": "2015"
    },
    {
      "DOI": "10.1128/EC.00090-14",
      "author": "M Peccarelli",
      "doi-asserted-by": "publisher",
      "first-page": "1126",
      "journal-title": "Eukaryot Cell",
      "key": "751_CR5",
      "unstructured": "Peccarelli M, Kebaara BW. Regulation of natural mRNAs by the nonsense-mediated mRNA decay pathway. Eukaryot Cell. 2014;13:1126–35.",
      "volume": "13",
      "year": "2014"
    },
    {
      "DOI": "10.1038/nchembio.304",
      "doi-asserted-by": "crossref",
      "key": "751_CR6",
      "unstructured": "Schneider-Poetsch T, Ju J, Eyler DE, Dang Y, Bhat S, Merrick WC, et al. Inhibition of eukaryotic translation elongation by cycloheximide and lactimidomycin. Nat Chem Biol. 2010;6:209–17."
    },
    {
      "DOI": "10.1016/bs.ircmb.2017.07.008",
      "author": "AJ Bergsma",
      "doi-asserted-by": "publisher",
      "first-page": "85",
      "journal-title": "Int Rev Cell Mol Biol",
      "key": "751_CR7",
      "unstructured": "Bergsma AJ, van der Wal E, Broeders M, van der Ploeg AT, Pim, Pijnappel WWM. Alternative splicing in genetic diseases: improved diagnosis and novel treatment options. Int Rev Cell Mol Biol. 2018;335:85–141.",
      "volume": "335",
      "year": "2018"
    },
    {
      "DOI": "10.1056/NEJMra1705346",
      "author": "AA Levin",
      "doi-asserted-by": "publisher",
      "first-page": "57",
      "journal-title": "N. Engl J Med",
      "key": "751_CR8",
      "unstructured": "Levin AA. Treating disease at the RNA level with oligonucleotides. N. Engl J Med. 2019;380:57–70.",
      "volume": "380",
      "year": "2019"
    },
    {
      "DOI": "10.1038/mtna.2016.75",
      "author": "AJ Bergsma",
      "doi-asserted-by": "publisher",
      "first-page": "e361",
      "journal-title": "Mol Ther Nucleic Acids",
      "key": "751_CR9",
      "unstructured": "Bergsma AJ, In ‘t Groen SL, Verheijen FW, van der Ploeg AT, Pijnappel W. From cryptic toward canonical pre-mRNA splicing in Pompe disease: a pipeline for the development of antisense oligonucleotides. Mol Ther Nucleic Acids. 2016;5:e361.",
      "volume": "5",
      "year": "2016"
    },
    {
      "DOI": "10.1016/j.omtn.2017.03.002",
      "author": "E van der Wal",
      "doi-asserted-by": "publisher",
      "first-page": "101",
      "journal-title": "Mol Ther Nucleic Acids",
      "key": "751_CR10",
      "unstructured": "van der Wal E, Bergsma AJ, van Gestel TJM, In ‘t Groen SLM, Zaehres H, Arauzo-Bravo MJ, et al. GAA deficiency in Pompe disease is alleviated by exon inclusion in iPSC-derived skeletal muscle cells. Mol Ther Nucleic Acids. 2017;7:101–15.",
      "volume": "7",
      "year": "2017"
    },
    {
      "DOI": "10.1016/j.omtn.2017.03.001",
      "author": "E van der Wal",
      "doi-asserted-by": "publisher",
      "first-page": "90",
      "journal-title": "Mol Ther Nucleic Acids",
      "key": "751_CR11",
      "unstructured": "van der Wal E, Bergsma AJ, Pijnenburg JM, van der Ploeg AT, Pijnappel W. Antisense oligonucleotides promote exon inclusion and correct the common c.-32-13T\u003eG GAA splicing variant in Pompe disease. Mol Ther Nucleic Acids. 2017;7:90–100.",
      "volume": "7",
      "year": "2017"
    },
    {
      "DOI": "10.1016/j.ymthe.2017.05.019",
      "doi-asserted-by": "crossref",
      "key": "751_CR12",
      "unstructured": "Goina E, Peruzzo P, Bembi B, Dardis A, Buratti E. Glycogen reduction in myotubes of late-onset Pompe disease patients using antisense technology. Mol Ther. 2017;25:2117–28."
    },
    {
      "DOI": "10.1002/humu.22981",
      "author": "JT den Dunnen",
      "doi-asserted-by": "publisher",
      "first-page": "564",
      "journal-title": "Hum Mutat",
      "key": "751_CR13",
      "unstructured": "den Dunnen JT, Dalgleish R, Maglott DR, Hart RK, Greenblatt MS, McGowan-Jordan J, et al. HGVS recommendations for the description of sequence variants: 2016 update. Hum Mutat. 2016;37:564–9.",
      "volume": "37",
      "year": "2016"
    },
    {
      "DOI": "10.1212/01.wnl.0000252798.25690.76",
      "author": "MA Kroos",
      "doi-asserted-by": "publisher",
      "first-page": "110",
      "journal-title": "Neurology",
      "key": "751_CR14",
      "unstructured": "Kroos MA, Pomponio RJ, Hagemans ML, Keulemans JL, Phipps M, DeRiso M, et al. Broad spectrum of Pompe disease in patients with the same c.-32-13T-\u003eG haplotype. Neurology. 2007;68:110–5.",
      "volume": "68",
      "year": "2007"
    },
    {
      "DOI": "10.4172/2161-0665.1000290",
      "doi-asserted-by": "crossref",
      "key": "751_CR15",
      "unstructured": "Takahashi S, Tanaka R, Okano S, Okayama A, Suzuki N, Azuma H. Reduced efficacy of enzyme replacement therapy in a child with late-onset Pompe disease. Pediatrics Therapeutics. 2016;6:2."
    },
    {
      "DOI": "10.1038/jhg.2009.66",
      "author": "M Maimaiti",
      "doi-asserted-by": "publisher",
      "first-page": "493",
      "journal-title": "J Hum Genet",
      "key": "751_CR16",
      "unstructured": "Maimaiti M, Takahashi S, Okajima K, Suzuki N, Ohinata J, Araki A, et al. Silent exonic mutation in the acid-alpha-glycosidase gene that causes glycogen storage disease type II by affecting mRNA splicing. J Hum Genet. 2009;54:493–6.",
      "volume": "54",
      "year": "2009"
    },
    {
      "DOI": "10.1016/S0960-8966(00)00142-5",
      "author": "S Tsujino",
      "doi-asserted-by": "publisher",
      "first-page": "599",
      "journal-title": "Neuromuscul Disord",
      "key": "751_CR17",
      "unstructured": "Tsujino S, Huie M, Kanazawa N, Sugie H, Goto Y, Kawai M, et al. Frequent mutations in Japanese patients with acid maltase deficiency. Neuromuscul Disord. 2000;10:599–603.",
      "volume": "10",
      "year": "2000"
    },
    {
      "DOI": "10.1093/nar/gkt987",
      "author": "A Dardis",
      "doi-asserted-by": "publisher",
      "first-page": "1291",
      "journal-title": "Nucleic Acids Res",
      "key": "751_CR18",
      "unstructured": "Dardis A, Zanin I, Zampieri S, Stuani C, Pianta A, Romanello M, et al. Functional characterization of the common c.-32-13T\u003eG mutation of GAA gene: identification of potential therapeutic agents. Nucleic Acids Res. 2014;42:1291–302.",
      "volume": "42",
      "year": "2014"
    },
    {
      "DOI": "10.1007/s00439-017-1779-6",
      "author": "PD Stenson",
      "doi-asserted-by": "publisher",
      "first-page": "665",
      "journal-title": "Hum Genet",
      "key": "751_CR19",
      "unstructured": "Stenson PD, Mort M, Ball EV, Evans K, Hayden M, Heywood S, et al. The Human Gene Mutation Database: towards a comprehensive repository of inherited mutation data for medical research, genetic diagnosis and next-generation sequencing studies. Hum Genet. 2017;136:665–77.",
      "volume": "136",
      "year": "2017"
    },
    {
      "DOI": "10.1073/pnas.1101135108",
      "author": "KH Lim",
      "doi-asserted-by": "publisher",
      "first-page": "11093",
      "journal-title": "Proc Natl Acad Sci USA",
      "key": "751_CR20",
      "unstructured": "Lim KH, Ferraris L, Filloux ME, Raphael BJ, Fairbrother WG. Using positional distribution to identify splicing elements and predict pre-mRNA processing defects in human genes. Proc Natl Acad Sci USA. 2011;108:11093–8.",
      "volume": "108",
      "year": "2011"
    },
    {
      "DOI": "10.1038/ng.3837",
      "author": "R Soemedi",
      "doi-asserted-by": "publisher",
      "first-page": "848",
      "journal-title": "Nat Genet",
      "key": "751_CR21",
      "unstructured": "Soemedi R, Cygan KJ, Rhine CL, Wang J, Bulacan C, Yang J, et al. Pathogenic variants that alter protein code often disrupt splicing. Nat Genet. 2017;49:848–55.",
      "volume": "49",
      "year": "2017"
    },
    {
      "DOI": "10.1016/j.ebiom.2019.03.048",
      "author": "AJ Bergsma",
      "doi-asserted-by": "publisher",
      "first-page": "553",
      "journal-title": "EBioMedicine",
      "key": "751_CR22",
      "unstructured": "Bergsma AJ, In ‘t Groen SLM, van den Dorpel JJA, van den Hout H, van der Beek N, Schoser B, et al. A genetic modifier of symptom onset in Pompe disease. EBioMedicine. 2019;43:553–61.",
      "volume": "43",
      "year": "2019"
    },
    {
      "DOI": "10.1016/j.cell.2019.02.032",
      "author": "T Lappalainen",
      "doi-asserted-by": "publisher",
      "first-page": "70",
      "journal-title": "Cell",
      "key": "751_CR23",
      "unstructured": "Lappalainen T, Scott AJ, Brandt M, Hall IM. Genomic analysis in the age of human genome sequencing. Cell. 2019;177:70–84.",
      "volume": "177",
      "year": "2019"
    },
    {
      "DOI": "10.1038/ejhg.2010.188",
      "author": "S Zampieri",
      "doi-asserted-by": "publisher",
      "first-page": "422",
      "journal-title": "Eur J Hum Genet",
      "key": "751_CR24",
      "unstructured": "Zampieri S, Buratti E, Dominissini S, Montalvo AL, Pittis MG, Bembi B, et al. Splicing mutations in glycogen-storage disease type II: evaluation of the full spectrum of mutations and their relation to patients’ phenotypes. Eur J Hum Genet. 2011;19:422–31.",
      "volume": "19",
      "year": "2011"
    },
    {
      "DOI": "10.1002/humu.1380020406",
      "author": "MM Hermans",
      "doi-asserted-by": "publisher",
      "first-page": "268",
      "journal-title": "Hum Mutat",
      "key": "751_CR25",
      "unstructured": "Hermans MM, Kroos MA, de Graaff E, Oostra BA, Reuser AJ. Two mutations affecting the transport and maturation of lysosomal alpha-glucosidase in an adult case of glycogen storage disease type II. Hum Mutat. 1993;2:268–73.",
      "volume": "2",
      "year": "1993"
    },
    {
      "author": "CF Boerkoel",
      "first-page": "887",
      "journal-title": "Am J Hum Genet",
      "key": "751_CR26",
      "unstructured": "Boerkoel CF, Exelbert R, Nicastri C, Nichols RC, Miller FW, Plotz PH, et al. Leaky splicing mutation in the acid maltase gene is associated with delayed onset of glycogenosis type II. Am J Hum Genet. 1995;56:887–97.",
      "volume": "56",
      "year": "1995"
    },
    {
      "DOI": "10.1093/hmg/3.7.1081",
      "author": "ML Huie",
      "doi-asserted-by": "publisher",
      "first-page": "2231",
      "journal-title": "Hum Mol Genet",
      "key": "751_CR27",
      "unstructured": "Huie ML, Chen AS, Tsujino S, Shanske S, DiMauro S, Engel AG, et al. Aberrant splicing in adult onset glycogen storage disease type II (GSDII): molecular identification of an IVS1 (-13T-\u003eG) mutation in a majority of patients and a novel IVS10 (+1GT-\u003eCT) mutation. Hum Mol Genet. 1994;3:2231–6.",
      "volume": "3",
      "year": "1994"
    },
    {
      "DOI": "10.1002/humu.23867",
      "doi-asserted-by": "crossref",
      "key": "751_CR28",
      "unstructured": "Goina E, Musco L, Dardis A, Buratti E. Assessment of the functional impact on the pre-mRNA splicing process of 28 nucleotide variants associated with Pompe disease in GAA exon 2 and their recovery using antisense technology. Hum Mutat. 2019;40:2121–30."
    },
    {
      "DOI": "10.5858/arpa.2016-0622-RA",
      "author": "M Hegde",
      "doi-asserted-by": "publisher",
      "first-page": "798",
      "journal-title": "Arch Pathol Lab Med",
      "key": "751_CR29",
      "unstructured": "Hegde M, Santani A, Mao R, Ferreira-Gonzalez A, Weck KE, Voelkerding KV. Development and validation of clinical whole-exome and whole-genome sequencing for detection of germline variants in inherited disease. Arch Pathol Lab Med. 2017;141:798–805.",
      "volume": "141",
      "year": "2017"
    },
    {
      "DOI": "10.1038/nrg.2016.10",
      "author": "SA Byron",
      "doi-asserted-by": "publisher",
      "first-page": "257",
      "journal-title": "Nat Rev Genet",
      "key": "751_CR30",
      "unstructured": "Byron SA, Van Keuren-Jensen KR, Engelthaler DM, Carpten JD, Craig DW. Translating RNA sequencing into clinical diagnostics: opportunities and challenges. Nat Rev Genet. 2016;17:257–71.",
      "volume": "17",
      "year": "2016"
    },
    {
      "DOI": "10.1016/j.ajhg.2019.01.012",
      "author": "HD Gonorazky",
      "doi-asserted-by": "publisher",
      "first-page": "466",
      "journal-title": "Am J Hum Genet",
      "key": "751_CR31",
      "unstructured": "Gonorazky HD, Naumenko S, Ramani AK, Nelakuditi V, Mashouri P, Wang P, et al. Expanding the boundaries of RNA sequencing as a diagnostic tool for rare Mendelian disease. Am J Hum Genet. 2019;104:466–83.",
      "volume": "104",
      "year": "2019"
    },
    {
      "DOI": "10.1016/j.tig.2015.01.001",
      "author": "E de Klerk",
      "doi-asserted-by": "publisher",
      "first-page": "128",
      "journal-title": "Trends Genet",
      "key": "751_CR32",
      "unstructured": "de Klerk E, t Hoen PA. Alternative mRNA transcription, processing, and translation: insights from RNA sequencing. Trends Genet. 2015;31:128–39.",
      "volume": "31",
      "year": "2015"
    },
    {
      "DOI": "10.1016/j.ymthe.2017.03.023",
      "author": "CA Stein",
      "doi-asserted-by": "publisher",
      "first-page": "1069",
      "journal-title": "Mol Ther",
      "key": "751_CR33",
      "unstructured": "Stein CA, Castanotto D. FDA-approved oligonucleotide therapies in 2017. Mol Ther. 2017;25:1069–75.",
      "volume": "25",
      "year": "2017"
    },
    {
      "DOI": "10.1007/s40265-018-0983-6",
      "author": "SM Hoy",
      "doi-asserted-by": "publisher",
      "first-page": "1625",
      "journal-title": "Drugs",
      "key": "751_CR34",
      "unstructured": "Hoy SM. Patisiran: first global approval. Drugs. 2018;78:1625–31.",
      "volume": "78",
      "year": "2018"
    },
    {
      "DOI": "10.1002/jimd.12251",
      "doi-asserted-by": "publisher",
      "key": "751_CR35",
      "unstructured": "Kuijper EC, Bergsma AJ, Pim Pijnappel WWM, Aartsma-Rus A. Opportunities and challenges for antisense oligonucleotide therapies. J Inherit Metab Dis. 2020. https://doi.org/10.1002/jimd.12251. online ahead of print."
    },
    {
      "DOI": "10.1016/j.ymgmr.2017.10.009",
      "author": "Y Fukuhara",
      "doi-asserted-by": "publisher",
      "first-page": "3",
      "journal-title": "Mol Genet Metab Rep",
      "key": "751_CR36",
      "unstructured": "Fukuhara Y, Fuji N, Yamazaki N, Hirakiyama A, Kamioka T, Seo JH, et al. A molecular analysis of the GAA gene and clinical spectrum in 38 patients with Pompe disease in Japan. Mol Genet Metab Rep. 2018;14:3–9.",
      "volume": "14",
      "year": "2018"
    }
  ],
  "reference-count": 36,
  "references-count": 36,
  "resource": {
    "primary": {
      "URL": "https://www.nature.com/articles/s41431-020-00751-3"
    }
  },
  "score": 0,
  "short-container-title": [
    "Eur J Hum Genet"
  ],
  "source": "Crossref",
  "title": [
    "A generic assay for the identification of splicing variants that induce nonsense-mediated decay in Pompe disease"
  ],
  "type": "journal-article",
  "update-policy": "http://dx.doi.org/10.1007/springer_crossmark_policy",
  "volume": "29"
}